Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 129 publications
A dual diacylglycerol kinase (DGK) alpha/zeta inhibitor augments the activity of human tumor infiltrating lymphocytes in in vivo and ex vivo models.
Journal: Oncoimmunology
Published: December 29, 2025
Taking "Multiple Shots on Goal" with an Armed Invariant NK Cell Approach.
Journal: Cancer immunology research
Published: October 27, 2025
Neoadjuvant intratumoral immune stimulation using gene-mediated cytotoxic immunotherapy for resectable non-small cell lung cancer: 5-Year outcomes.
Journal: JTCVS open
Published: October 15, 2025
Phase 1 study of autologous T cells bearing fully human chimeric antigen receptors targeting mesothelin in mesothelin-expressing cancers.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: August 12, 2025
CAR T cells targeting CCR4 selectively deplete human Tregs ex vivo and in vivo.
Journal: Blood advances
Published: June 24, 2025
Targeted Lipid Nanoparticle Delivery of FAP-CAR mRNA Enables Potent In Vivo T-cell Engineering against Pancreatic Tumors.
Journal: Cancer immunology research
Published: June 02, 2025
Identification and characterization of tissue resident memory T cells in malignant pleural effusions associated with non-small cell lung cancer.
Journal: ImmunoHorizons
Published: March 04, 2025
In Situ Tumor Vaccination Using Lipid Nanoparticles to Deliver Interferon-β mRNA Cargo.
Journal: Vaccines
Published: December 31, 2024
PD-1 Blockade Mitigates Surgery-Induced Immunosuppression and Increases the Efficacy of Photodynamic Therapy for Pleural Mesothelioma.
Journal: Cancer research communications
Published: November 18, 2024
Editor's Note: Multiple Injections of Electroporated Autologous T Cells Expressing a Chimeric Antigen Receptor Mediate Regression of Human Disseminated Tumor.
Journal: Cancer research
Published: August 14, 2024
Last Updated: 09/26/2026